angiogenin

Angiogenin (108-122) TFA is an angiogenin peptide.Angiogenin (108-122) acts as a therapeutic agent for the prophylaxis and/or treatment of cancer, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, an autoimmu

Angiogenin (108-122) is an angiogenin peptide that serves as a therapeutic agent for the prophylaxis and/or treatment of cancer, infectious diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, autoimmune diseases, and heart and vascular diseases.

Angiogenin Fragment (108-123) acetate is the C-terminal fragment 108-123 of angiogenin, inhibiting both its enzymatic and biological activities.

Neomycin sulfate (Framycin sulfate) is a broad-spectrum aminoglycoside antibiotic that blocks the synthesis of bacterial proteins in order to exert antimicrobial activity. Neomycin sulfate is commonly used to screen prokaryotic and eukaryotic cells for Neo resistance genes.

Angiogenin Fragment (108-123) is a C-terminal segment, comprising amino acids 108 to 123, that inhibits the enzymatic and biological activities of the parent protein Angiogenin [1].

Neamine, a broad-spectrum aminoglycoside antibiotic derived from Neomycin, exhibits potent antibacterial, antitumor, and neuroprotective activities. As an anti-angiogenesis agent, it specifically targets angiogenin [1] [2].